Recent Advances in Searching for DNMT Inhibitors and Their Potential Application in Treating Human Diseases

Area of Science:

• Epigenetics
• Molecular Biology
• Pharmacology

Background:

• DNA methylation is a crucial epigenetic mechanism controlling gene expression.
• DNA methyltransferases (DNMTs) are vital enzymes that establish and maintain DNA methylation patterns.
• Dysfunctional DNMTs are implicated in diseases, including cancer, due to aberrant gene methylation.

Purpose of the Study:

• To provide a comprehensive overview of DNMTs, encompassing their structure and biological roles.
• To review the therapeutic development of DNMT inhibitors, highlighting historical and current advancements.

Main Methods:

• This is a narrative review, synthesizing existing scientific literature.
• Key studies on DNMT structure, function, and inhibitor development were analyzed.

Main Results:

• DNMTs play essential roles in dynamic epigenetic regulation across cell types.
• The reversibility of DNA methylation makes DNMTs attractive targets for drug development.
• Significant progress has been made in developing DNMT inhibitors as potential therapeutics.

Conclusions:

• DNMTs are critical epigenetic regulators whose dysfunction contributes to disease.
• DNMT inhibitors represent a promising therapeutic strategy for various conditions, particularly cancer.
• Continued research into DNMTs and their inhibitors holds potential for novel treatment approaches.